Deep Medicine Acquisition... (DMAQ)
NASDAQ: DMAQ
· Real-Time Price · USD
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 10:00 PM
Company Description
Deep Medicine Acquisition Corp. does not have significant operations.
The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
It focuses on identifying businesses in the healthcare industry.
The company was incorporated in 2020 and is based in New York, New York.
Deep Medicine Acquisition Corp.
| Country | United States |
| IPO Date | Dec 2, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Humphrey P. Polanen |
Contact Details
Address: 595 Madison Avenue New York City, New York United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | DMAQ |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001857086 |
| CUSIP Number | 243733102 |
| ISIN Number | US2437331026 |
| Employer ID | 85-3269086 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Humphrey P. Polanen | Chief Executive Officer & Chairman of the Board |
| Weixuan Luo CPA, MS | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 04, 2025 | 8-K | Current Report |
| Jul 30, 2025 | 8-K | Current Report |
| Jul 22, 2025 | 8-K | Current Report |
| Jul 18, 2025 | S-1/A | [Amend] Filing |
| Jul 16, 2025 | 4 | Filing |
| Jun 24, 2025 | 8-K | Current Report |
| Jun 20, 2025 | S-1 | Filing |
| Jun 03, 2025 | 8-K | Current Report |
| May 29, 2025 | 8-K | Current Report |
| May 22, 2025 | DEFA14A | Filing |